Galectin-7 Human Recombinant, LGALS7 Human, 10ug

CAT No.BT-CYT-016

Galectin-7 Human Recombinant, LGALS7 Human, 10ug

---

Amino acid sequence

The sequence of the first five N-terminal amino acids was determined and was found to be Ser-Asn-Val-Pro-His.

Biological Activity

The ED50 of Galectin-7 as determined by hemagglutination test is 0.75~3 ug/ml.

Description

Galectin-7 Human Recombinant produced in E.Coli is a single, non-glycosylated, Polypeptide chain containing 135 amino acids and having a molecular mass of 15kDa.
The LGALS7 is purified by proprietary chromatographic techniques.

LGALS7 was lyophilized from a concentrated (1mg/ml) solution in 20mM PBS, pH 7.4.

Physical Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.

Purity
Greater than 95.0% as determined by:
(a) Analysis by RP-HPLC.
(b) Analysis by SDS-PAGE.

Solubility

It is recommended to reconstitute the lyophilized Galectin-7 in sterile 18M?-cm H2O not less than 100ug/ml, which can then be further diluted to other aqueous solutions.

Source
Escherichia Coli.

Stability
Lyophilized LGALS7 although stable at room temperature for 3 weeks, should be stored desiccated below -18¡ãC. Upon reconstitution Galectin-7 should be stored at 4¡ãC between 2-7 days and for future use below -18¡ãC.
Please prevent freeze-thaw cycles.

Synonyms

Galectin-7, Gal-7, HKL-14, PI7, p53-induced gene 1 protein, LGALS7, PIG1, LGALS7B, GAL7, LGALS7A.

Usage
TSZGENE's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.